liothyronine sodium

Generic: liothyronine sodium

Labeler: teva pharmaceuticals usa, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name liothyronine sodium
Generic Name liothyronine sodium
Labeler teva pharmaceuticals usa, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

liothyronine sodium 5 ug/1

Manufacturer
Teva Pharmaceuticals USA, Inc.

Identifiers & Regulatory

Product NDC 0093-2179
Product ID 0093-2179_22ed1e76-c20a-481e-bc00-2b531d14c3e4
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA211510
Listing Expiration 2026-12-31
Marketing Start 2021-02-26

Pharmacologic Class

Classes
triiodothyronine [cs] l-triiodothyronine [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00932179
Hyphenated Format 0093-2179

Supplemental Identifiers

RxCUI
903456 903697 903703
UPC
0300932180017 0300932178014
UNII
GCA9VV7D2N

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name liothyronine sodium (source: ndc)
Generic Name liothyronine sodium (source: ndc)
Application Number ANDA211510 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 5 ug/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (0093-2179-01)
source: ndc

Packages (1)

Ingredients (1)

liothyronine sodium (5 ug/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "22ed1e76-c20a-481e-bc00-2b531d14c3e4", "openfda": {"upc": ["0300932180017", "0300932178014"], "unii": ["GCA9VV7D2N"], "rxcui": ["903456", "903697", "903703"], "spl_set_id": ["548d684a-86f5-4e57-9844-d8cf0a84e068"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (0093-2179-01)", "package_ndc": "0093-2179-01", "marketing_start_date": "20210226"}], "brand_name": "Liothyronine Sodium", "product_id": "0093-2179_22ed1e76-c20a-481e-bc00-2b531d14c3e4", "dosage_form": "TABLET", "pharm_class": ["Triiodothyronine [CS]", "l-Triiodothyronine [EPC]"], "product_ndc": "0093-2179", "generic_name": "Liothyronine Sodium", "labeler_name": "Teva Pharmaceuticals USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Liothyronine Sodium", "active_ingredients": [{"name": "LIOTHYRONINE SODIUM", "strength": "5 ug/1"}], "application_number": "ANDA211510", "marketing_category": "ANDA", "marketing_start_date": "20210226", "listing_expiration_date": "20261231"}